Back to Top

The Journal of Pathology (TJP)

Publisher :

John Wiley & Sons, Inc

Scopus Profile
Peer reviewed only
Scopus Profile
Open Access
  • Pathology
e-ISSN :

1096-9896

Issue Frequency :

Monthly

Impact Factor :

5.6

p-ISSN :

0022-3417

Est. Year :

1892

Mobile :

441865776868

Country :

United Kingdom

Language :

English

APC :

YES

Impact Factor Assignee :

Google Scholar

Email :

Managing_Editor@jpathol.org

Journal Descriptions

The Journal of Pathology aims to serve as a translational bridge between basic biomedical science and clinical medicine with particular emphasis on, but not restricted to, tissue based studies. The main interests of the Journal lie in publishing studies that further our understanding the pathophysiological and pathogenetic mechanisms of human disease. The Journal welcomes investigative studies on human tissues, in vitro and in vivo experimental studies, and investigations based on animal models with a clear relevance to human disease, including transgenic systems. In general, hypothesis driven studies that appropriately employ multiple investigative techniques are preferred over those that rely on a single methodology. As well as original research papers, the Journal seeks to provide rapid publication in a variety of other formats, including editorials, review articles, commentaries and perspectives and other features, both contributed and solicited.


The Journal of Pathology (TJP) is :

International, Peer-Reviewed, Open Access, Refereed, Pathology , Online or Print, Monthly Journal

UGC Approved, ISSN Approved: P-ISSN - 0022-3417, E-ISSN - 1096-9896, Established in - 1892, Impact Factor - 5.6

Not Provide Crossref DOI

Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE

Publications of TJP

  • dott image January, 1994

An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms

Immunohistochemical detection of intranuclear p53 gene product may indicate mutation of the p53 suppressor gene on chromosome 17p. We used six commercially available antibodies for p53 immun...

Establish Your Own Journal Without the Expense!

OJSCloud offers a complete, free setup to get you publishing.

Start Your Free Journal!
free profile